1159 Results

People

  1. Tuttle
    Tuttle
  2. Kolesnick
    Kolesnick
  3. Fagin
    Fagin
  4. Ghossein
    Ghossein
  5. Shaha
    Shaha
  6. Fuks
    Fuks
  7. Ganly
    Ganly
  8. Haimovitz-Friedman
    Haimovitz-Friedman
  9. Shah
    Shah
  10. Patel
    Patel

Groups

  1. Department of Medicine (1159)
  2. Division of Subspecialty Medicine (1159)
  3. Endocrinology (1159)
  4. Survivorship Research (583)
  5. GSK Faculty (528)
  6. Sloan Kettering Institute Faculty (352)
  7. Molecular Pharmacology and Chemistry Program Faculty (347)
  8. Surgery (297)
  9. Department of Pathology and Laboratory Medicine (202)
  10. Human Oncology and Pathogenesis Program (198)
  1. "Endocrinology"
Formats
  1. Journal Article (773)
  2. Meeting Abstract (242)
  3. Review (45)
  4. Book Section (37)
  5. Editorial (34)
  6. Correspondence (9)
  7. Guidelines (9)
  8. Conference Paper (3)
  9. Research Letter (3)
  10. Book Whole (2)
  11. Miscellaneous (2)
Groups
  1. Department of Medicine (1159)
  2. Division of Subspecialty Medicine (1159)
  3. Endocrinology (1159)
  4. Survivorship Research (583)
  5. GSK Faculty (528)
  6. Sloan Kettering Institute Faculty (352)

More Groups

People
  1. Robert Tuttle (481)
  2. Richard Kolesnick (299)
  3. James Fagin (180)
  4. Ronald Ghossein (175)
  5. Ashok Shaha (164)
  6. Zvi Fuks (131)

More People

Years
  1. 2025 (13)
  2. 2024 (49)
  3. 2023 (49)
  4. 2022 (83)
  5. 2021 (58)
  6. 2020 (62)

More Years

Publications
  1. Thyroid (114)
  2. Cancer Research (58)
  3. Journal of Clinical Endocrinology and Metabolism (49)
  4. Journal of Clinical Oncology (42)
  5. Journal of Biological Chemistry (38)
  6. International Journal of Radiation Oncology, Biology, Physics (26)

More Publications

Publishers
  1. Elsevier Inc. (117)
  2. Mary Ann Liebert, Inc (116)
  3. Springer (97)
  4. American Association for Cancer Research (90)
  5. Oxford University Press (71)
  6. Wiley Blackwell (67)

More Publishers

Results (1159)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to: Letter to the editor regarding the article "Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma"
    Journal Article

    Boucai, L.; Wang, L. Y.; Smith, A. W.; Palmer, F. L.; Mahrous, A.; Tuttle, R. M.; Fagin, J. A.
    Thyroid (2015)

    Fulltext@MSK | Save
  • Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence
    Journal Article

    Pitoia, F.; Jerkovich, F.; Urciuoli, C.; Schmidt, A.; Abelleira, E.; Bueno, F.; Cross, G.; Tuttle, R. M.
    Thyroid (2015)

    Fulltext@MSK | Save
  • Denosumab and fracture risk in women with breast cancer
    Journal Article

    Farooki, A.; Fornier, M.
    Lancet (2015)

    Fulltext@MSK | Save
  • Intraductal papillary mucinous neoplasms and the risk of diabetes mellitus in patients undergoing resection versus observation
    Journal Article

    Leal, J. N.; Kingham, T. P.; D'Angelica, M. I.; DeMatteo, R. P.; Jarnagin, W. R.; Kalin, M. F.; Allen, P. J.
    Journal of Gastrointestinal Surgery (2015)

    Fulltext@MSK | Save
  • Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: A clinicopathologic study of 276 cases
    Journal Article

    Xu, B.; Wang, L.; Tuttle, R. M.; Ganly, I.; Ghossein, R.
    Human Pathology (2015)

    Fulltext@MSK | Save
  • Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke
    Journal Article

    Floyd, J. S.; Wiggins, K. L.; Sitlani, C. M.; Flory, J. H.; Dublin, S.; Smith, N. L.; Heckbert, S. R.; Psaty, B. M.
    Diabetes, Obesity and Metabolism (2015)

    Fulltext@MSK | Save
  • NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition
    Journal Article

    Garcia-Rendueles, M. E. R.; Ricarte-Filho, J. C.; Untch, B. R.; Landa, I.; Knauf, J. A.; Voza, F.; Smith, V. E.; Ganly, I.; Taylor, B. S.; Persaud, Y.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Undetectable thyroglobulin levels in poorly differentiated thyroid carcinoma patients free of macroscopic disease after initial treatment: Are they useful?
    Journal Article

    Ibrahimpasic, T.; Ghossein, R.; Carlson, D. L.; Nixon, I. J.; Palmer, F. L.; Patel, S. G.; Tuttle, R. M.; Shaha, A.; Shah, J. P.; Ganly, I.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Survival from differentiated thyroid cancer: What has age got to do with it?
    Journal Article

    Ganly, I.; Nixon, I. J.; Wang, L. Y.; Palmer, F. L.; Migliacci, J. C.; Aniss, A.; Sywak, M.; Eskander, A. E.; Freeman, J. L.; Campbell, M. J.; more...
    Thyroid (2015)

    Fulltext@MSK | Save
  • Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
    Journal Article

    Wiesner, T.; Lee, W.; Obenauf, A. C.; Ran, L.; Murali, R.; Zhang, Q.; Wong, E. W. P.; Hu, W.; Scott, S. N.; Shah, R. H.; more...
    Nature (2015)

    Fulltext@MSK | Save